Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Notch Signaling Exhibits a Tumor Suppressor Function in Gliomas

DOI: 10.1158/2159-8290.CD-RW2015-234 Published February 2016
  • Article
  • Info & Metrics
Loading
  • Major finding: Loss of Notch signaling enhances the growth of PDGF-driven Trp53-null forebrain tumors.

  • Mechanism: Co-inactivation of p53 and Notch signaling induces malignant transformation of NSCs.

  • Impact: Targeting Notch signaling in certain glioma subtypes may enhance tumorigenesis.

Gliomas are the most common adult brain malignancy and have a poor prognosis, which may be due in part to the presence of a stem-like cell subpopulation that has been shown to be radio- and chemoresistant and to phenotypically resemble neural stem cells (NSC). Although Notch signaling, which is integral for NSC maintenance, has been suggested to play an oncogenic role in some brain tumors, the role of this pathway in glioma remains unclear. Giachino and colleagues interrogated the role of Notch signaling using mouse models of glioma driven by platelet-derived growth factor (PDGF) expression and loss of Trp53 (PDGF+/Trp53−/−) and a reporter mouse in which GFP expression was driven by the promoter of the transcription factor HES5 as a readout of activated Notch signaling. In early-stage PDGF+/Trp53−/− gliomas, HES5 was expressed in only a subpopulation of glioma cells. Targeted expression of PDGF and deletion of Trp53 in HES5+ Notch signaling cells resulted in glioma initiation. Surprisingly, deletion of the Notch mediator recombination signal binding protein for immunoglobulin κ J region (Rbpj) accelerated the growth of PDGF+/Trp53−/− gliomas which were mostly composed of HES5− proliferating cells. Late-stage PDGF+/Trp53−/−/Rbpj−/- gliomas exhibited features of poorly differentiated supratentorial primitive neuroectodermal tumors (sPNET) and proneural/mesenchymal glioblastoma gene signatures. Furthermore, co-deletion of Notch1 and Notch2 in PDGF+/Trp53−/− tumors resulted in accelerated development of malignant glioma, and co-deletion of Rbpj and Trp53 in quiescent NSCs induced the development of premalignant NSCs and highly penetrant sPNET-like tumors. In patients with proneural glioblastoma, HES5 expression was inversely correlated with survival, and the expression of HES5, RBPJ, and the Notch-induced transcription factors HEY1 and HEY2 was associated with better prognosis in grade II and III astrocytomas. Together, these results show that Notch signaling has a tumor-suppressor function in grade II–III astrocytomas, proneural glioblastomas, and sPNETs.

Giachino C, Boulay JL, Ivanek R, Alvarado A, Tostado C, Lugert S, et al. A tumor suppressor function for Notch signaling in forebrain tumor subtypes. Cancer Cell 2015 Dec 5 [Epub ahead of print].

  • ©2015 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 6 (2)
February 2016
Volume 6, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Notch Signaling Exhibits a Tumor Suppressor Function in Gliomas
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Notch Signaling Exhibits a Tumor Suppressor Function in Gliomas
Cancer Discov February 1 2016 (6) (2) OF6; DOI: 10.1158/2159-8290.CD-RW2015-234

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Notch Signaling Exhibits a Tumor Suppressor Function in Gliomas
Cancer Discov February 1 2016 (6) (2) OF6; DOI: 10.1158/2159-8290.CD-RW2015-234
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
  • Cryo-EM Structures Reveal Mechanism of Anticancer MCT1 Inhibitors
  • Computational Tool Characterizes Previously Unidentified Tumor Subtypes
Show more Research Watch

Glioma

  • Distinct Transitional States of Glial Progenitors Drive Gliomagenesis
  • Unique Molecular Landscapes Distinguish Low- and High-Grade NF1 Gliomas
  • (R)-2HG Inhibits the BCAT Transaminase in IDH-Mutant Glioma
Show more Glioma
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement